Fallopian tube cancer stage IV

2 trials 2 recruiting MedDRA PT
2 Registered trials
2 Recruiting
2 Unique sponsors
2 Unique IMPs
0 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
PARP inhibitor 1 substance
Colony-stimulating factor 1 substance
Phase III: 1 Phase II: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Arcagy Gineco Academic
    FILGRASTIM
    2023-508260-30-01 3 countries 2024 n=145
    Recruiting

Phase II

1 trial
  • Nord Ostdeutsche Gesellschaft Fuer Gynaekologische Onkologie e.V. Academic
    NIRAPARIB TOSILATE MONOHYDRATE
    2022-502559-69-01 6 countries 2024 n=640 Orphan
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Nord Ostdeutsche Gesellschaft Fuer Gynaekologische Onkologie e.V. Academic 1 Phase II 1
Arcagy Gineco Academic 1 Phase III 1
New trials by year
2024
2
← All indication landscapes